These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 4895062

  • 1. Vascular symptomatic relief during administration of ethylchlorophenoxyisobutyrate (clofibrate).
    Albert M, Stansell MJ.
    Metabolism; 1969 Aug; 18(8):635-45. PubMed ID: 4895062
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA, de Bulhões F, Tuma M.
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract] [Full Text] [Related]

  • 3. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N.
    Acta Med Scand; 1970 Mar 03; 187(3):213-8. PubMed ID: 5444978
    [No Abstract] [Full Text] [Related]

  • 4. Peripheral vascular disease improved by clofibrate.
    Exp Med Surg; 1968 Mar 03; 26(4):277-9. PubMed ID: 5736504
    [No Abstract] [Full Text] [Related]

  • 5. The Coronary Drug Project. Initial findings leading to modifications of its research protocol.
    JAMA; 1970 Nov 16; 214(7):1303-13. PubMed ID: 4320008
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of arteriosclerosis by Atromid].
    Ayad H.
    Rev Med Moyen Orient; 1967 Nov 16; 24(6):504-11. PubMed ID: 5264185
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical studies with a new anticoronaritis preparation].
    Amadini S, Bagnoli L.
    Minerva Cardioangiol; 1969 Aug 16; 17(8):532-48. PubMed ID: 5402252
    [No Abstract] [Full Text] [Related]

  • 8. [Currently used therapeutic agents for arteriosclerosis--with special reference to a protein anabolic hormone, clofibrate (C.P.I.B.)].
    Yasugi T, Sasa E.
    Nihon Rinsho; 1970 May 16; 28(5):1470-4. PubMed ID: 4915308
    [No Abstract] [Full Text] [Related]

  • 9. [Currently used therapeutic agents for arteriosclerosis--with special reference ro a protein anabolic hormone, clofibrate (C.P.I.B.)].
    Yasugi T, Sasa E.
    Nihon Rinsho; 1970 May 16; 28(5):1470-4. PubMed ID: 4916330
    [No Abstract] [Full Text] [Related]

  • 10. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS, Mann JI, Truswell AS, Levy I.
    S Afr Med J; 1975 Apr 05; 49(15):631-4. PubMed ID: 1094562
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of clofibrate therapy in peripheral arteriopathy].
    Begg TB, Rifkind BM.
    Minerva Med; 1971 Sep 26; 62(72):3469-75. PubMed ID: 5097219
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of essential hyperlipidaemia.
    Fredrickson DS, Levy RI.
    Lancet; 1970 Jan 24; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract] [Full Text] [Related]

  • 14. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML, Setty KR, Roy SB.
    J Assoc Physicians India; 1971 Feb 24; 19(2):123-9. PubMed ID: 4934418
    [No Abstract] [Full Text] [Related]

  • 15. [Therapeutic possibilities in coronary disease].
    Zoli I, Baroncini S, Cornia GL, Donato S, Minore G, Pigini G, Pretolani E.
    Minerva Med; 1973 Nov 24; 64(84):4445-57. PubMed ID: 4272415
    [No Abstract] [Full Text] [Related]

  • 16. Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia.
    Howard AN, Hyams DE.
    Br Med J; 1971 Jul 03; 3(5765):25-7. PubMed ID: 4933388
    [Abstract] [Full Text] [Related]

  • 17. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF.
    Lakartidningen; 1971 Apr 07; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy.
    Harrold BP, Marmion VJ, Gough KR.
    Diabetes; 1969 May 07; 18(5):285-91. PubMed ID: 4894161
    [No Abstract] [Full Text] [Related]

  • 20. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A, Rodset JM.
    Acta Med Scand; 1971 May 07; 189(5):385-9. PubMed ID: 5578488
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.